VeriMominositol은 임신 중 안전한가요?
No harmonised ECHA reproductive classification was found for myo‑inositol (CAS 87‑89‑8) and the Cosmetic Ingredient Review (CIR) draft safety assessment (June 2024) reviews inositol use in cosmetics and focuses on local/topical effects, concluding systemic exposure from cosmetics is much lower than dietary/medical exposures. Clinical literature shows myo‑inositol has been studied as an oral supplement during pregnancy (e.g., trials/meta‑analyses of gestational diabetes prevention) without signals of teratogenicity, indicating therapeutic/oral use rather than topical cosmetic use is not associated with reproductive hazard in humans. Sources: CIR safety assessment; PubMed meta‑analyses; ECHA registration summary.
Pregnancy-safe products containing inositol
Related ingredients
Frequently asked questions
- inositol은 임신 중 안전한가요?
- No harmonised ECHA reproductive classification was found for myo‑inositol (CAS 87‑89‑8) and the Cosmetic Ingredient Review (CIR) draft safety assessment (June 2024) reviews inositol use in cosmetics and focuses on local/topical effects, concluding systemic exposure from cosmetics is much lower than dietary/medical exposures. Clinical literature shows myo‑inositol has been studied as an oral supplement during pregnancy (e.g., trials/meta‑analyses of gestational diabetes prevention) without signals of teratogenicity, indicating therapeutic/oral use rather than topical cosmetic use is not associated with reproductive hazard in humans. Sources: CIR safety assessment; PubMed meta‑analyses; ECHA registration summary.
- inositol은 모유 수유 중 안전한가요?
- No evidence of reproductive or lactation‑specific hazard from topical inositol use was identified. Clinical/peer‑reviewed studies address oral supplementation (systemic use) in pregnancy with no flagged lactation/teratogenic concerns; CIR explicitly frames cosmetic topical exposure as primarily local and low systemic. No harmonised CLP classification or SCCS/Safety opinion contraindicating use in lactation was found.
- inositol은 아기 피부에 안전한가요?
- No infant‑specific hazard or developmental toxicity evidence for inositol applied topically to infants (0–3 y) was found. CIR states topical exposures are low; however, because inositol is water‑soluble and not completely non‑absorbable, immature infant skin gives higher per‑kg exposure, so exposure score is increased by +1 for baby skin while hazard and mechanism remain 0 absent infant‑specific adverse data.
- VeriMom은 inositol을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 inositol을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 inositol 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.